Europe on track to miss 2030 hepatitis elimination goal

New data suggests Europe is likely to miss the World Health Organization target of eliminating viral hepatitis by 2030. The assessment, reported by News-Medical, points to persistent gaps in testing, treatment, and awareness across the continent.

Viral hepatitis, which inflames the liver and can lead to cirrhosis or cancer, remains a significant public health challenge. The WHO set 2030 as the deadline for reducing new infections and deaths by 90% and 65%, respectively. Europe's current trajectory falls short.

Testing and treatment gaps

A key obstacle is that many people with hepatitis B or C do not know they are infected. The disease often shows no symptoms until advanced stages. Without widespread testing, patients miss the chance for early treatment that can prevent liver damage.

Treatment coverage also remains uneven. While direct-acting antivirals can cure most cases of hepatitis C, access varies by country. Some nations have robust screening programs, while others lag due to cost or infrastructure issues.

India's fight against hepatitis

In India, the government has stepped up efforts to combat the disease. The Press Information Bureau reported that Ripon Buildings in Kolkata were illuminated in green to mark World Hepatitis Day. The symbolic gesture aimed to raise public awareness about the 'silent epidemic.'

Public health campaigns in India emphasize early testing. The Times of India highlighted warning signs of hepatitis, including jaundice, dark urine, fatigue, and abdominal pain. Doctors urge people with risk factors — such as exposure to contaminated needles or blood — to get tested promptly.

Symptoms and prevention

Common symptoms include yellowing of the skin and eyes, nausea, vomiting, and loss of appetite. However, many infected individuals show no signs for years. The NDTV report stressed that hepatitis can be prevented through vaccination (for types A and B), safe hygiene practices, and avoiding shared needles.

Treatment depends on the type. Hepatitis A usually resolves on its own. Hepatitis B may require antiviral medication. Hepatitis C is now curable with oral drugs taken for 8-12 weeks. Early detection is critical to prevent long-term liver damage.

What to watch

Governments and health agencies must accelerate testing campaigns and ensure treatment reaches marginalized populations. Without urgent action, the 2030 target will remain out of reach for Europe and other regions.